搜尋結果
2024年3月29日 · Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that it has entered into an agreement to divest its rights for vertigo and equilibrium disturbance treatment Merislon ® (generic name: betahistine mesilate) and muscle relaxant ®
Brand name. Merislon Tablets 6mg. Eisai Co., Ltd. Word. 日本語. The information on this sheet is based on approvals granted by the Japanese regulatory authority. Approval details may vary by country. Medicines have adverse reactions (risks) as well as efficacies (benefits). It is important to minimize adverse reactions and maximize efficacy.
製品概要. ※ご使用にあたっては 電子添文 をご確認ください. 剤形名. メリスロン錠6mgの添付文書、インタビューフォームなどの情報を掲載しています。 エーザイの医療関係者向け情報サイトです。 医療用医薬品を適正にご使用いただくための情報を提供しています。
東京都文京区小石川4-6-10. めまい・平衡障害治療剤; 総称名:メリスロン; 一般名:ベタヒスチンメシル酸塩; 販売名:メリスロン錠6mg, メリスロン錠12mg; 製造会社:エーザイ.
2022年11月7日 · Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that it has entered into an agreement to divest its rights for muscle relaxant Myonal ® (generic name: eperisone hydrochloride) and vertigo and equilibrium disturbance treatment Merislon ® (generic name: betahistine mesilate) in Asia (9 countries/regions*) to a subs...
2024年3月29日 · Merislon and Myonal have been widely used by patients in Japan for a long time since their launch in 1969 and 1983, respectively. Eisai has determined that divesting rights for these products to Kaken, which has strengths in the products’ disease areas, is the most optimal choice to ensure them to continue contributing to a greater ...
藥品成分. 詳細說明. ★★★醫師為何開此藥? 梅尼艾氏病、暈眩、聽力障礙。 ★★★如何使用此藥? 確實依照醫師指示使用，不可任意突然停藥。 ★★★使用此藥時該注意什麼? 1.抗組織胺劑會降低本藥的療效，因此不可合併使用。 2.請將本劑連同藥袋放置於室溫之陰涼乾燥處避光儲存，請勿冷藏或冷凍。 請勿放在孩童可以取得的場所。 3.服用此藥期間如需服用其它藥品時，請主動告訴您的醫師或藥師。 ★★★此藥品可能引起的副作用及處理方式： 若症狀持續數日或嚴重時，請停藥並立即就醫或與醫師連絡。 1.可能會有腸胃不適、頭暈、頭痛、疲倦或失眠的症狀，停藥後通常這些症狀便會消失。 2.若有紅疹或癢，可能是藥物過敏的現象，請先停止服用再與醫師連絡或就診。 ★★★忘記服藥時該怎麼辦：
2024年3月29日 · TOKYO, Mar 29, 2024 - (JCN Newswire) - Eisai Co., Ltd. announced today that it has entered into an agreement to divest its rights for vertigo and equilibrium disturbance treatment Merislon® (generic name: betahistine mesilate) and muscle relaxant Myonal® (generic name: eperisone hydrochloride) in Japan to Kaken Pharmaceutical Co., Ltd.
2024年3月29日 · Eisai Co., Ltd. announced today that it has entered into an agreement to divest its rights for vertigo and equilibrium disturbance treatment Merislon (generic name: betahistine mesilate) and muscle relaxant Myonal (generic name: eperisone hydrochloride) in Japan to Kaken Pharmaceutical Co., Ltd.
2024年3月30日 · Eisai Co., Ltd. announced today that it has entered into an agreement to divest its rights for vertigo and equilibrium disturbance treatment Merislon® (generic name: betahistine mesilate) and muscle relaxant Myonal® (generic name: eperisone hydrochloride) in Japan to Kaken Pharmaceutical Co., Ltd.
